TITLE 16             OCCUPATIONAL AND PROFESSIONAL LICENSING

CHAPTER 16     OPTOMETRIC PRACTITIONERS

PART 8                 DEA REGISTRATION REQUIREMENTS

 

16.16.8.1               ISSUING AGENCY: New Mexico Board of Optometry.

[10-14-95; 16.16.8.1 NMAC - Rn, 16 NMAC 16.8.1, 03-15-2001; A, 03-22-2008; A, 07-06-2012]

 

16.16.8.2               SCOPE: Part 8 of Chapter 16 applies to all New Mexico.

[10-14-95; 16.16.8.2 NMAC - Rn, 16 NMAC 16.8.2, 03-15-2001; A, 03-02-2016]

 

16.16.8.3               STATUTORY AUTHORITY: The authority for Part 8 of Chapter 16 is NMSA 1978, Section 61-2-10.2, Section 61-2-14.A, Section 61-2-6.D. (2) (1995 Repl. Pamp.).

[10-14-95; 16.16.8.3 NMAC - Rn, 16 NMAC 16.8.3, 03-15-2001]

 

16.16.8.4               DURATION: Permanent.

[10-14-95; 16.16.8.4 NMAC - Rn, 16 NMAC 16.8.4, 03-15-2001]

 

16.16.8.5               EFFECTIVE DATE: October 14, 1995, unless a later date is cited at the end of a section.

[10-14-95; 10-15-97; 16.16.8.5 NMAC - Rn, 16 NMAC 16.8.5, 03-15-2001; A, 03-22-2008]

 

16.16.8.6               OBJECTIVE: The objective of Part 8 of Chapter 16 is to inform optometrists of the procedures  to complete for certification before the optometrist can administer, dispense, and prescribe dangerous controlled substances in the treatment and management of ocular disease and conditions as provided in NMSA 1978 Section 61-2-10.2 (1995 Repl. Pamp.).

[10-14-95; 1616.8.6 NMAC - Rn, 16 NMAC 16.8.6, 03-15-2001; A, 03-02-2016]

 

16.16.8.7               DEFINITIONS:

                A.            “DEA” means the United States drug enforcement administration.

                B.            “dangerous controlled substances’ means a drug or substance listed in Schedules I through V of the Controlled Substances Act.

                C.            “Board of Pharmacy” means the New Mexico board of pharmacy.

[10-14-95; 16.16.8.7 NMAC - Rn, 16 NMAC 16.8.7, 03-15-2001]

 

16.16.8.8               PRE-DEA REGISTRATION REQUIREMENTS:

                A.            All New Mexico optometric physicians must first register with the New Mexico board of pharmacy and the United States drug enforcement administration (DEA).

                B.            Upon receipt of official recognition and authorization from the DEA, the board will send the board of pharmacy an official list, as required by the board of pharmacy, of all board licensees who have met the required qualifications and have received the proper board certification as provided by Section 61-2-10.2 of the Optometry Act.

[10-14-95; 16.16.8.8 NMAC - Rn, 16 NMAC 16.8.8, 03-15-2001; A, 03-02-2016]

 

16.16.8.9               DEA REGISTRATION REQUIREMENTS FOR CERTIFIED OPTOMETRISTS:

                A.            Upon completion of the board of pharmacy's requirements, and upon receipt of a New Mexico registration for controlled substances from the board of pharmacy, the optometrist shall apply for a DEA registration number from the DEA.

                B.            Upon receipt of a DEA registration number, the optometrist may administer, dispense, or prescribe dangerous controlled substances as provided in 16.16.7 NMAC for the treatment and management of ocular disease.

[10-14-95; 10-15-97; 16.16.8.9 NMAC - Rn, 16 NMAC 16.8.9, 03-15-2001; A, 07-06-2012; A, 03-02-2016]

 

HISTORY of 16.16.8 NMAC:

Pre-NMAC History:  None.

 

History of Repealed Material:  [Reserved]

 

Other History:

16 NMAC 16.8, DEA Registration Requirements, filed 9-21-95, renumbered and reformatted to 16.16.8 NMAC, DEA Registration Requirements, effective 03-15-2001.